Wolverine Asset Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACW
MF
SCM
CL
AA
PAMP
LP
LA
Wolverine Asset Management's TDACW Position: Q1 2026 in Review
Wolverine Asset Management reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 3% in Q1 2026, selling an estimated $719 and leaving 103,336 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1415.
Wolverine Asset Management first reported a position in TDACW in Q2 2025 and has held it in 4 quarters since. The position peaked at $41.7K in Q3 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.
- Wolverine Asset Management held 103,336 shares of Translational Development Acquisition Corp Warrants worth $12.4K as of Q1 2026.
- Wolverine Asset Management sold 3,143 Translational Development Acquisition Corp Warrants shares in Q1 2026, an estimated $719.
- Translational Development Acquisition Corp Warrants made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1415 holding.
- Wolverine Asset Management first reported a position in Translational Development Acquisition Corp Warrants in Q2 2025 and has held it in 4 quarters since.
- Wolverine Asset Management's Translational Development Acquisition Corp Warrants position peaked at $41.7K in Q3 2025.
- 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.
Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.